Renaud L, Wencel J, Pagès A, Al Jijakli A, Moatti H, Quero L, Camus V, Brice P. Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma. haematol [Internet]. 2024Sep.1 [cited 2024Dec.27];109(9):3019-23. Available from: https://haematologica.org/article/view/haematol.2023.284689